Literature DB >> 26833721

Injection scheme for intravitreal bevacizumab therapy for macular oedema due to central retinal vein occlusion: results of a multicentre study.

Gesine B Szurman1,2, Kai Januschowski1,2, Peter Szurman1,2, Nicolas Feltgen3, Bernhard Spitzer4, Amelie Pielen5, Matus Rehak6, Georg Spital7, Spyridon Dimopoulos1, Carsten H Meyer8.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 26833721     DOI： 10.1111/aos.12976

Source DB:  PubMed          Journal:  Acta Ophthalmol        ISSN： 1755-375X            Impact factor:   3.761


× No keyword cloud information.
  1 in total

1.  Predictive factors for functional improvement following intravitreal bevacizumab injections after central retinal vein occlusion.

Authors:  Gesine B Szurman; Carsten H Meyer; Nicolas Feltgen; Amelie Pielen; Bernhard Spitzer; Matus Rehak; Georg Spital; Spyridon Dimopoulos; Peter Szurman; Kai Januschowski
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2017-02-21       Impact factor: 3.117
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.